|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 1/04 | (2006.01) |
| (11) | Number of the document | 1641793 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04749051.1 |
| Date of filing the European patent application | 2004-06-23 | |
| (97) | Date of publication of the European application | 2006-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2008-02-13 |
| (46) | Date of publication of the claims translation | 2008-05-26 |
| (86) | Number | PCT/SE2004/001013 |
| Date | 2004-06-23 |
| (87) | Number | WO 2004/113339 |
| Date | 2004-12-29 |
| (30) | Number | Date | Country code |
| 0301904 | 2003-06-26 | SE |
| (72) |
NORDBERG, Peter, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Naujas imidazopiridino junginys II, pasižymintis terapiniu poveikiu |
| NOVEL IMIDAZOPYRIDINE COMPOUND II WITH THERAPEUTIC EFFECT |
| Payment date | Validity (years) | Amount | |
| 2009-05-20 | 6 | 480.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-06-23 |